Caldera Therapeutics
PrivateLast Round
Series A
Extension
Jan 14, 2026
Total Funding Raised
$112.5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Caldera Therapeutics is a clinical stage biotechnology company developing CLD-423, a first-in-class bispecific antibody for the treatment of inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Caldera Therapeutics Comparables
Compare Caldera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bionyra Pharma | 94% | |
| TrueLab Biopharmaceutical | 88% | |
| Spyre Therapeutics Inc. | 84% |
Caldera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 14, 2026 | ||||
| Series A | Apr 23, 2025 |
Caldera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A Extension |
| Omega Funds | Series A Extension |
| Accomplice | Series A Extension, Series A |
| venBio | Series A Extension, Series A |
| Wellington Management | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 3, 2026
Grew 42% QoQ, from 12 to 17 employees.
- Aug 21, 2026
Monthly visitors grew 108% MoM, reaching 4.2K.
Recent news
Latest coverage and updates
- merges_withJul 30, 2026
Caldera Therapeutics, Inc. was planning to merge with Synlogic Inc. on Jul 30th '26.
- receives_financingJul 29, 2026
Caldera Therapeutics, Inc. was planning to receive financing of $278M in private placement financing on Jul 29th '26.
Caldera Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Caldera Therapeutics's valuation, stock price, and market status.
Is Caldera Therapeutics a public or private company?
Caldera Therapeutics is a private company.
What is the current stock price of Caldera Therapeutics?
Caldera Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Caldera Therapeutics worth (valuation)?
Valuation information for Caldera Therapeutics is not publicly available.
Can I buy Caldera Therapeutics stock?
Caldera Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Caldera Therapeutics's last funding round?
Caldera Therapeutics's most recent funding round was Series A Extension on January 14, 2026.
Who are the main investors in Caldera Therapeutics?
Key investors in Caldera Therapeutics include Omega Funds.
Will Caldera Therapeutics IPO soon?
No public IPO plans have been announced for Caldera Therapeutics.
How can I track Caldera Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Caldera Therapeutics's secondary market activity and sign up for updates.